Revenue of $599 million decreased 24% compared to prior year; pro forma revenue decreased 10% GAAP EPS of $0.03 increased from $(3.53) in the prior year; adjusted EPS of $0.51 decreased 40% compared to prior year Achieved $30 million of run-rate cost synergies associated with Linxis and...
Related Questions
How will the 24% revenue decline affect the company's cash flow and liquidity position?
What are the primary drivers behind the revenue decline and are they temporary or structural?
How sustainable are the $30 million run‑rate cost synergies from the Linxis integration?
What guidance did management provide for the next quarter and full fiscal year 2025?
How does the 40% decline in adjusted EPS compare with peer companies in the same sector?
What is the outlook for gross margin and operating expenses going forward?
Has the company revised its capital allocation plan (share buybacks, dividends, debt reduction) in light of the earnings?
What is the current forward P/E ratio versus historical averages and peers?
How will the market likely price in the EPS improvement from $(3.53) to $0.03?
What are the key risks and catalysts that could move the stock in the next 12 months?